Tools for molecular risk-stratification for clinical puposes: CLL as a prototype

European Journal of Human Genetics

Volumn 12, Issue 6, 2004, Pages 423-

  de Jong, Daphne ^a   van't Veer, Laura J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN; MOLECULAR MARKER; PROTEIN KINASE ZAP 70; TRASTUZUMAB;

BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC PARAMETERS; HIGH RISK POPULATION; HUMAN; MEDICAL DECISION MAKING; MOLECULAR CLONING; MOLECULAR GENETICS; NEUROBLASTOMA; NOTE; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC SCREENING; GENOMIC INSTABILITY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MOLECULAR BIOLOGY; PROGNOSIS; RISK FACTORS;

EID: 3142745327     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201220     Document Type: Note

References (12)

1. Schwaenen C et al : Proc Natl Acad Sci USA 2004; 101: 1039-1044.
2. Keating MJ et al: American Society of Hematology Educational Book, 2003, pp. 165-169.
3. Rosenwald A et al: J Exp Med 2001; 194: 1639-1647.
4. Wiestner et al: Blood 2003; 101: 1944-4951.
5. Crespo M et al: N Engl J Med 2003; 348: 1764-1775.
6. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Blood 1999; 94: 1848-1854.
7. Damle RN et al: Blood 1999; 94: 1840-1847.
8. Krober A et al: Blood 2002; 100: 1410-1416.
9. Dohner et al: N Engl J Med 2000; 343: 1910-1916.
10. Hogervorst FB et al: Cancer Res 2003; 63: 1449-1453.
11. Ibrahim S et al: Blood 2003; 101: 4944-4951.
12. Hamblin TJ et al: Blood 2002; 99: 1023-1029.